BRAF mutations are the primary drivers of melanoma in younger patients, while in older patients, neither NRAS nor BRAF was mutated in nearly half of the patients who were tested, suggesting a polygenic or lesser-known genetic driver. The gene discussed is NRAS; the disease is melanoma.